Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MetLife    MET

METLIFE (MET)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Earnings Review and Free Research Report: MetLife’s Q2 Bottom-line Surged 57% Y-o-Y; Outshined Forecasts

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/18/2017 | 01:42pm CEST

Research Desk Line-up: Manulife Financial Post Earnings Coverage

LONDON, UK / ACCESSWIRE / August 18, 2017 /Pro-Trader Daily has just published a free post-earnings coverage on MetLife, Inc. (NYSE: MET), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=MET, following the Company's disclosure of its financial results on August 02, 2017, for the second quarter fiscal 2017 (Q2 FY17). The New York-based Company's operating earnings per share surged 57% y-o-y; outperforming market consensus estimates. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:

http://protraderdaily.com/register/

Get more of our free earnings reports coverage from other constituents of the Life Insurance industry. Pro-TD has currently selected Manulife Financial Corporation (NYSE: MFC) for due-diligence and potential coverage as the Company announced on August 09, 2017, its financial results for Q2 2017. Register for a free membership today, and be among the early birds that get access to our report on Manulife Financial when we publish it.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on MET; also brushing on MFC. With the links below you can directly download the report of your stock of interest free of charge at:

http://protraderdaily.com/optin/?symbol=MET

http://protraderdaily.com/optin/?symbol=MFC

Earnings Reviewed

During Q2 FY17, MetLife reported total revenues of $17.25 billion, up from $15.24 billion in the previous year's same quarter. The Company's total operating revenues came in at $17.39 billion for the eported quarter, up 3% from $16.96 billion recorded at the end of Q2 FY16. Wall Street had expected the Company to report total operating revenues of $17.13 billion for the reported quarter. Furthermore, operating premiums, fees & other revenues were $12.50 billion for Q2 FY17 compared to $12.07 billion in the prior year's same quarter.

The insurance corporation reported net income available to MetLife's common shareholders of $838 million, or $0.77 per share, in Q2 FY17 compared to $64 million, or $0.06 per share, in Q2 FY16. The Company's operating earnings grew to $1.41 billion, or $1.30 per share, during Q2 FY17 from $924 million, or $0.83 per share, in Q2 FY16. Market analysts had expected operating earnings of $1.28 per share.

Operating Metrics

The Company reported a return on equity (ROE) of 5.0% in Q2 FY17 compared to a 0.3% in Q2 FY16. MetLife's operating ROE (excluding AOCI other than FCTA) for the reported quarter was 6.2% compared to 0.4% in Q2 FY16. The Company's operating tangible ROE in Q2 FY17 was 7.6% versus 0.6% in Q2 FY16. Furthermore, book value per tangible common stockholders' equity stood at $42.00 as on June 30, 2017, compared to $43.98 as on June 30, 2016.

Segment-Performance

U.S. - The segment's operating revenues increased to $7.90 billion in Q2 FY17 from $7.18 billion in Q2 FY16. Total premiums revenues also grew to $5.88 billion in Q2 FY17 from $5.17 billion in the last year's comparable quarter. Furthermore, the segment's operating earnings rose 13% to $499 million y-o-y in Q2 FY17.

Asia - In Q2 FY17, operating revenues from the segment was $2.77 billion compared to $2.75 billion in the prior year's same quarter. The segment's premiums revenues were $1.66 billion in Q2 FY17 compared to $1.68 billion in Q2 FY16. Moreover, operating earnings from Asia increased 20% to $310 million y-o-y in Q2 FY17.

Latin America -MetLife's Latin American segment generated operating revenues of $1.22 billion in Q2 FY17 compared to $1.15 billion in Q2 FY16. The segment's total premiums revenues increased to $645 million during Q2 FY17 from $631 million in Q2 FY16. Additionally, the segment's operating earnings were up by 12% y-o-y to stand at $154 million in Q2 FY17.

EMEA - During Q2 FY17, the segment's operating revenues stood at $703 million compared to $716 million in Q2 FY16. Total premiums were $505 million for Q2 FY17 versus $519 million in Q2 FY16. Meanwhile, the segment's operating earnings rose 13% to $72 million y-o-y in Q2 FY17.

MetLife Holdings - For Q2 FY17, the segment reported operating revenues of $2.81 billion compared to $3.16 billion in the year ago same quarter. The segment's premiums revenues stood at $1.02 billion for Q2 FY17 versus $1.12 billion in Q2 FY16. Furthermore, the segment's operating earnings came in at $235 million for Q2 FY17 versus operating loss of $33 million in the previous year's corresponding period.

Brighthouse Financial - The segment's operating revenues were $2.07 billion for Q2 FY17, which came in below the $2.36 billion reported in the year ago same quarter. Operating earnings fell 5% y-o-y to $283 million in the reported quarter.

Dividend and Share Buyback

In a separate press release on July 07, 2017, MetLife's Board of Directors declared third quarter FY17 common stock dividend of $0.40 per share. The dividend is payable on September 13, 2017, to shareholders of record as of August 07, 2017.

During Q2 FY17, MetLife repurchased $952 million of its common shares.

Spin-Off

On August 07, 2017, MetLife completed the spin-off of Brighthouse Financial, Inc. (NASDAQ: BHF), creating two independent, publicly-traded companies.

Stock Performance

At the closing bell, on Thursday, August 17, 2017, MetLife's stock slipped 2.09%, ending the trading session at $46.95. A total volume of 7.68 million shares have exchanged hands, which was higher than the 3-month average volume of 5.76 million shares. The Company's stock price soared 5.77% in the last three months and 30.44% in the previous twelve months. The stock is trading at a PE ratio of 484.02 and has a dividend yield of 3.41%. The stock currently has a market cap of $49.83 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE:Pro-Trader Daily

Copyright © 2017 accesswire. All Rights Reserved., source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on METLIFE
08/18 EARNINGS REVIEW AND FREE RESEARCH RE : MetLife’s Q2 Bottom-line Surged 57%..
08/18 METLIFE : Earnings Review and Free Research Report: MetLife’s Q2 Bottom-line Sur..
08/18 METLIFE : Daily Technical Summary Reports on Insurance Stocks -- Genworth Financ..
08/18 METLIFE : Launches Second Startup Engagement Program, "collab 2.0"
08/17 METLIFE : Launches Second Startup Engagement Program, “collab 2.0”
08/15 METLIFE INC : Other Events, Financial Statements and Exhibits (form 8-K)
08/15 METLIFE : Declares Third Quarter 2017 Preferred Stock Dividend
08/10 METLIFE : CFO John Hele Provides Second Quarter 2017 Financial Update Video
08/10 DELOITTE : Pivotal Voted the Ultimate Award Recipient in the 2017 WhatWorks® Awa..
08/10 METLIFE INC : Other Events, Financial Statements and Exhibits (form 8-K)
More news
News from SeekingAlpha
08/19 BRIGHTHOUSE FINANCIAL : Too Cheap To Ignore
08/14 Banks lead S&P rally
08/10 MetLife ups estimate of net investment losses related to Brighthouse spin
08/10 Blame It On The Millennials - Cramer's Mad Money (8/9/17)
08/08 Brighthouse Financial limps out of the gate after MetLife spinoff
Financials ($)
Sales 2017 65 617 M
EBIT 2017 6 007 M
Net income 2017 4 224 M
Debt 2017 -
Yield 2017 3,43%
P/E ratio 2017 13,28
P/E ratio 2018 9,22
Capi. / Sales 2017 0,76x
Capi. / Sales 2018 0,76x
Capitalization 49 976 M
Chart METLIFE
Duration : Period :
MetLife Technical Analysis Chart | MET | US59156R1086 | 4-Traders
Technical analysis trends METLIFE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 55,2 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Steven Albert Kandarian Chairman, President & Chief Executive Officer
Martin J. Lippert Executive VP-Global Technology & Operations
John C. R. Hele Chief Financial Officer & Executive Vice President
Jacki Goldstein Chief Medical Officer
Cheryl W. Grisé Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
METLIFE-12.88%49 976
AXA3.31%70 424
PRUDENTIAL11.28%60 247
PRUDENTIAL FINANCIAL INC-1.35%43 876
MANULIFE FINANCIAL CORP.1.07%38 509
AFLAC INCORPORATED14.71%31 555